All Cancer articles
-
FeatureBlood biopsies for cancer
Testing small amounts of blood for the presence of disease markers could revolutionise how we detect cancer. Clare Sansom reports
-
BusinessPan-cancer approval shows huge potential for antibody–drug conjugates
Enhertu gains approval based on gene expression rather than tumour location
-
ResearchAlgorithm designs proteins from scratch that can bind drugs and small molecules
Strategy could stop an overdose or produce an antidote to a poison
-
BusinessBig deals confirm renewed interest in radiopharmaceuticals
Acquisitions of RayzeBio and Point Biopharma highlight the potential of targeting radioactivity directly to tumour cells
-
BusinessIllumina to give up Grail as competition appeals fail
Sequencing giant will sell off its former spin-out in accordance with regulator orders
-
BusinessLife-saving cancer gene therapy under investigation after being linked to rare secondary cancers
US drug agency examining six CAR-T therapies after reports of T-cell malignancies
-
-
BusinessThree US juries side with cancer victims over Bayer on Roundup
Bayer unit Monsanto has lost its ‘winning streak’ of nine defence verdicts, and the company plans to appeal
-
BusinessUS proposes complete ban on trichloroethylene
If implemented, most uses would be phased out within a year, with limited exemptions
-
OpinionSurviving in the war of all against all
Cancers and bacteria develop resistance to drugs in remarkably similar ways
-
BusinessJ&J subsidiary sues more talc researchers
Lawsuit claims another study linking talc use to cancer is fraudulent
-
FeatureAre hair relaxers damaging to health?
Different chemistries have been designed to turn curly hair straight, but in all cases questions remain about their safety, finds Rachel Brazil
-
NewsRepercussions of Bhopal disaster found to echo on down through generations
Women pregnant in the city at the time of deadly accident gave birth to children who have higher risk of cancer
-
NewsCancer research charity to ‘reluctantly’ close after 22 years
UK’s National Cancer Research Institute to shut its doors
-
NewsThe subterranean chemistry that explains India’s groundwater contamination
Complex interplay of factors has led to elevated levels of arsenic, uranium and fluoride in drinking water, making the country’s poorest citizens sick
-
BusinessJ&J proposes to pay nearly $9 billion to settle talc lawsuits
Company re-files for bankruptcy of a subsidiary in the hopes of resolving tens of thousands of claims its products caused cancer
-
ResearchBiocompatible battery starves cancer cells of oxygen
Implantable self-charging battery creates hypoxic conditions to help kill tumour cells
-
BusinessPfizer to buy cancer biotech Seagen for $43 billion
Antibody-drug conjugate specialist will fill Pfizer’s cancer pipeline
-
BusinessJ&J subsidiary claims key talc research is fraudulent
Complaint alleges study that helped link talc to cancer contained false information
-
BusinessJudge dismisses ranitidine lawsuits over lack of evidence
Drug degrades to produce nitrosamines, but the judge ruled the link between this and plaintiffs’ cancers could not be proven